|
CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma |
|
|
|
Title: |
CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma |
Author: |
Kumai, Takumi Nagato, Toshihiro Kobayashi, Hiroya Komabayashi, Yuki Ueda, Seigo Kishibe, Kan Ohkuri, Takayuki Takahara, Miki Celis, Esteban Harabuchi, Yasuaki |
Appeared in: |
Cancer, immunology, immunotherapy |
Paging: |
Volume 64 (2015) nr. 6 pages 697-705 |
Year: |
2015 |
Contents: |
|
Publisher: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|